A Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal Cancer
Clinical trial NCT04227041 · UNKNOWN
Trial details
- NCT number
- NCT04227041
- Sponsor
- Qingdao Zhixin Health Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-10
- Primary completion
- 2021-01-10
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.